A detailed history of Kempen Capital Management N.V. transactions in Siga Technologies Inc stock. As of the latest transaction made, Kempen Capital Management N.V. holds 2,203,508 shares of SIGA stock, worth $16.7 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,203,508
Previous 2,274,359 3.12%
Holding current value
$16.7 Million
Previous $12.7 Million 48.1%
% of portfolio
0.24%
Previous 0.18%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$4.51 - $8.92 $319,538 - $631,990
-70,851 Reduced 3.12%
2,203,508 $18.9 Million
Q4 2023

Feb 14, 2024

BUY
$4.82 - $6.25 $1.66 Million - $2.15 Million
343,599 Added 17.8%
2,274,359 $12.7 Million
Q3 2023

Nov 14, 2023

SELL
$4.32 - $5.77 $1.09 Million - $1.46 Million
-253,083 Reduced 11.59%
1,930,760 $10.1 Million
Q2 2023

Aug 14, 2023

SELL
$5.0 - $6.31 $202,820 - $255,958
-40,564 Reduced 1.82%
2,183,843 $11 Million
Q1 2023

May 12, 2023

BUY
$5.23 - $8.42 $1.73 Million - $2.79 Million
331,052 Added 17.48%
2,224,407 $12.8 Million
Q4 2022

Feb 14, 2023

BUY
$7.29 - $10.14 $8.09 Million - $11.3 Million
1,110,171 Added 141.75%
1,893,355 $13.9 Million
Q3 2022

Nov 14, 2022

SELL
$10.02 - $26.15 $6.8 Million - $17.7 Million
-678,687 Reduced 46.43%
783,184 $8.07 Million
Q2 2022

Aug 15, 2022

BUY
$6.5 - $13.68 $551,778 - $1.16 Million
84,889 Added 6.16%
1,461,871 $16.9 Million
Q1 2022

May 13, 2022

BUY
$5.96 - $7.61 $1.34 Million - $1.71 Million
224,423 Added 19.47%
1,376,982 $9.76 Million
Q4 2021

Feb 11, 2022

BUY
$6.96 - $9.26 $1.35 Million - $1.8 Million
193,954 Added 20.23%
1,152,559 $8.67 Million
Q3 2021

Nov 15, 2021

BUY
$5.71 - $7.39 $5.47 Million - $7.08 Million
958,605 New
958,605 $7.08 Million

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $554M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Kempen Capital Management N.V. Portfolio

Follow Kempen Capital Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Kempen Capital Management N.V. with notifications on news.